Hyponatremia in critically ill neurological patients

被引:153
作者
Rabinstein, AA [1 ]
Wijdicks, EFM [1 ]
机构
[1] St Marys Hosp, Neurol Neurosurg Intens Care Unit, Rochester, MN USA
关键词
hyponatremia; NICU; cerebral salt wasting; natriuretic peptides; SIADH;
D O I
10.1097/01.nrl.0000095258.07720.89
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Hyponatremia is the most common and important electrolyte disorder encountered in the neurologic intensive care unit (NICU). Advances in our knowledge of the pathophysiological mechanisms at play in patients with acute neurologic disease have improved our understanding of this derangement. Review Summary: Evaluation of hyponatremia requires a structured approach beginning with the measurement of serum and urine osmolalities. Most cases of hyponatremia in the NICU are associated with serum hypotonicity. latrogenic causes, most conspicuously inadequate tonicity of intravenous fluids, should be promptly identified and removed when possible. Two main mechanisms are responsible for most noniatrogenic cases of hyponatremia in patients with neurologic or neurosurgical disease: inappropriate secretion of antidiuretic hormone (SIADH) and cerebral salt wasting syndrome (CSW). Distinction between these two syndromes may be difficult and must be based on an accurate assessment of the patient's volume status. SIADH is associated with normal or slightly expanded volume status and should be treated with fluid restriction. Patients with CSW are hypovolemic and require adequate fluid and sodium replacement. Correction of hyponatremia should not exceed 8 to 10 mmol/L over any 24-hour period to avoid the risk of osmotic demyelination. Conclusions: Hyponatremia may complicate the clinical course of many acute neurologic and neurosurgical disorders. It is most often iatrogenic causes, CSW, or SIADH. Physicians working with critically ill neurologic patients should be familiar with management strategies addressing these underlying pathophysiological mechanisms.
引用
收藏
页码:290 / 300
页数:11
相关论文
共 101 条
[41]  
Ke C, 2000, ACT NEUR S, V76, P405
[42]   ESCAPE FROM THE SODIUM-RETAINING EFFECTS OF MINERALOCORTICOIDS [J].
KNOX, FG ;
BURNETT, JC ;
KOHAN, DE ;
SPIELMAN, WS ;
STRAND, JC .
KIDNEY INTERNATIONAL, 1980, 17 (03) :263-276
[43]   Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm [J].
Kurokawa, Y ;
Uede, T ;
Ishiguro, M ;
Honda, O ;
Honmou, O ;
Kato, T ;
Wanibuchi, M .
SURGICAL NEUROLOGY, 1996, 46 (05) :500-507
[44]   CENTRAL PONTINE MYELINOLYSIS FOLLOWING RAPID CORRECTION OF HYPONATREMIA [J].
LAURENO, R .
ANNALS OF NEUROLOGY, 1983, 13 (03) :232-242
[45]   Myelinolysis after correction of hyponatremia [J].
Laureno, R ;
Karp, BI .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) :57-62
[46]  
Levin ER, 1998, NEW ENGL J MED, V339, P321
[47]   INADEQUATE ANTIDIURETIC-HORMONE SECRETION AFTER SAGITTAL SINUS THROMBOSIS CAUSED BY PROTEIN-S DEFICIENCY [J].
LIEDTKE, W .
STROKE, 1991, 22 (06) :819-819
[48]   Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure [J].
Lisy, O ;
Lainchbury, JG ;
Leskinen, H ;
Burnett, JC .
HYPERTENSION, 2001, 37 (04) :1089-1094
[49]   Cerebral salt-wasting syndrome: Does it exist? [J].
Maesaka, JK ;
Gupta, S ;
Fishbane, S .
NEPHRON, 1999, 82 (02) :100-109
[50]  
MAGOVERN JA, 1989, J CARDIOVASC SURG, V30, P544